Co-localisation of insulin-like growth factor II and the proliferation marker MIB1 in hepatocellular carcinoma cells

Journal of Clinical Pathology

Volumn 50, Issue 2, 1997, Pages 135-137

  Sohda, T ^a   Oka, Y ^a   Iwata, K ^a   Gunn, J ^b   Kamimura, S ^a   Shijo, H ^a   Okumura, M ^a   Yun, K ^b  

^a FUKUOKA UNIVERSITY   (Japan)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Autocrine paracrine growth; Human hepatocellular carcinoma; Insulin like growth factor II; Ki 67 antigen; Transcriptional regulation

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY KI 67; SOMATOMEDIN B;

ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

EID: 0031044206     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.2.135     Document Type: Article

References (14)

1. Moses AC, Nissley SP, Short PA, Rechler MM, White RM, Knight AB, et al. Increased levels of multiplication stimulation activity, an insulin-like growth factor, in fetal rat serum. Proc Natl Acad Sci USA 1980;77:3649-53.
2. Yun K. A new marker for rhabdomyosarcoma: Insulin-like growth factor II. Lab Invest 1992;67:653-64.
3. Yun K, Fidler AE, Eccles MR, Reeve AE. insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor. Cancer Res 1993;53:5166-71.
4. D'Arville CN, Nouri-Aria KT, Johnson P, Williams R. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma. Hepatology 1991;13:310-5.
5. Lamas E, LeBail B, Housset C, Boucher O, Brechot C. Localization of insulin-like growth factor-II and hepatitis B virus mRNAs and proteins in human hepatocellular carcinomas. Lab Invest 1991;64:98-104.
6. Su Q, Liu Y-F, Zhang J-F, Zhang S-X, Li D-F, Yang J-J. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Hepatology 1994; 19:788-99.
7. D'Errico A, Grigioni WF, Fiorentino M, Baccarini P, Lamas E, De Mitri MS, et al. Expression of insulin-like growth factor II (IGF-II) in human hepatocellular carcinomas: An immunohistochemical study. Pathol Int 1994;44:131-7.
8. Sporn MB, Todaro GJ. Autocrine secretion and malignant transformation of cells. N Engl J Med 1980;303:878-80.
9. Sporn MB, Robert AB. Autocrine growth factors and cancer. Nature 1985;313:745-7.
10. Tashiro H, Iwasaki H, Kikuchi M, Ogata K, Okazaki M. Giant cell tumors of tendon sheath, a single and multiple immunostaining analysis. Pathol Int 1995;45:147-55.
11. Grigioni WF, D'Errico A, Bacci F, Gaudio M, Mazziotti A, Gozzetti G, et al. Primary liver neoplasms, evaluation of proliferative index using MoAb Ki67. J Pathol 1989;158: 23-9.
12. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, et al. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 1994;269:13779-84.
13. Nardone G, Romano M, Calabro A, Pedone PV, de Sio I, Persico M, et al. Activation of fetal promoters of insulin-like growth factor II gene in hepatitis C virus, related chronic hepetitis, cirrhosis, and hepatocellular carcinoma. Hepatology 1996;23:1304-12.
14. Sohda T, Kamimura S, Iwata K, Shijo H, Okumura M. Immunohistochemical evidence of insulin-like growth factor II in human small hepatocellular carcinoma with hepatitis C virus infection: Relationship to fatty change in carcinoma cells. J Gastroenterol Hepatol 1997 (in press).